Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury

NCT07362745 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT07362745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07362745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
January 1, 2026
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage liver disease, fatty liver, ischaemia reperfusion injury of liver, liver failure, liver transplant; complications, postoperative complications